Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam Against Carbapenem-Resistant Enterobacteriaceae
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00642-17
Full Text
Open PDFAbstract
Available in full text
Date
June 19, 2017
Authors
Publisher
American Society for Microbiology